Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study

Mateusz Bartoszewicz; Sławomir Lech Czaban; Klaudia Bartoszewicz; Damian Kuźmiuk; Jerzy Robert Ładny

doi:10.1177/20499361231207178

Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study

Ther Adv Infect Dis. 2023 Oct 20:10:20499361231207178. doi: 10.1177/20499361231207178. eCollection 2023 Jan-Dec.

Authors

Mateusz Bartoszewicz¹, Sławomir Lech Czaban², Klaudia Bartoszewicz³, Damian Kuźmiuk², Jerzy Robert Ładny⁴

Affiliations

¹ Department of Anaesthesiology and Intensive Care, Medical University of Bialystok, Malmeda, Bialystok, Podlaskie, 15-089, Poland.
² Department of Anaesthesiology and Intensive Care, Medical University of Bialystok, Bialystok, Poland.
³ Department of Clinical Immunology, Medical University of Bialystok, Bialystok, Poland.
⁴ Department of Emergency Medicine, Medical University of Bialystok, Bialystok, Poland.

Abstract

Background: Intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19), have a high risk of developing bloodstream infections (BSIs). However, the characteristics of and risk factors for BSIs in these patients remain unclear.

Objective: We aimed to identify prevalent causative pathogens of BSI and related factors in critically ill patients with COVID-19.

Design: This was a single-center, retrospective cohort study.

Methods: We analyzed the clinical characteristics and outcomes of 201 ICU patients with COVID-19. Logistic regression analysis was conducted to identify factors associated with BSI occurrence. Furthermore, we identified the primary causative pathogens of BSIs. The study outcomes were death or ICU discharge.

Results: Among the 201 included patients, 43 (21.4%) patients developed BSI. The mortality rate was non-significantly higher in the BSI group than in the BSI group (65.1% versus 58.9%, p = 0.487). There were significant between-group differences in the obesity prevalence and sex distribution, but not corticosteroid usage. BSI occurrence was significantly associated with duration of mechanical ventilation (MV), presence of ventilator-associated pneumonia, use of neuromuscular blocking agents, length of stay in ICU (ICU LOS), high body mass index (BMI), and male sex. The main causative pathogens were Klebsiella pneumoniae, Acinetobacter baumannii, and Enterococcus faecalis. Multi-drug-resistant pathogens were found in 87% of cases. Regardless of the origin, the common risk factors for BSI were ICU LOS and MV duration. All BSIs were acquired within the hospital setting, with ≈60% of the cases being primary BSIs. A small proportion of the BSI cases were catheter-related (four cases, 6.2%). Ventilator-associated pneumonia and urinary tract infections were present in 25% and 9.4% of the BSI cases, respectively. On average, the first positive blood culture appeared ≈11.4 (±9.7) days after ICU admission.

Conclusion: Elucidating the risk factors for and common pathogens of BSI can inform prompt management and prevention of BSIs.

Keywords: COVID-19; bloodstream infections; intensive care unit.